Zoledronic Acid (Zometa) for the Management of Tumor-Induced Hypercalcemia (TIH) and Malignant Bone Pain (MBP) in the Community: A Feasibility Study
Phase of Trial: Phase IV
Latest Information Update: 07 Jul 2015
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Cancer pain; Malignant hypercalcaemia; Musculoskeletal pain
- Focus Therapeutic Use
- 16 Nov 2007 Status changed from recruiting to completed.
- 01 Nov 2005 New trial record.